Cleerly LABS vs syngo.CT CaScoring
AI Verdict
Choose Cleerly LABS if…
Choose Cleerly LABS if you require a comprehensive, AI-powered analysis of coronary CT angiography (CCTA) to detect, quantify, and characterize all types of atherosclerosis and stenosis, including soft and calcified plaque. This tool is ideal for personalized heart disease management, tracking disease progression over time, and assessing the likelihood of ischemia.
View Cleerly LABS →Choose syngo.CT CaScoring if…
Choose syngo.CT CaScoring if your primary need is quick and accurate quantification of calcified coronary lesions for cardiovascular risk assessment using standardized scores like Agatston. This solution is best suited for facilities already integrated with Siemens CT scanner systems and the syngo.via platform, where a one-time license purchase for dedicated calcium scoring is preferred.
View syngo.CT CaScoring →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Cleerly LABS | syngo.CT CaScoring |
|---|---|---|
| Pricing | Per analysis | Contact for pricing |
| Deployment | Cloud-based (AWS), web-based application, with on-site Cleerly Proxy for data transfer. | Integrated with Siemens CT scanner systems; operates as a post-processing application on the multi-user syngo.via client/server platform. |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Cleerly LABSCleerly LABS (Tool A) is a web-based, cloud-deployed application, offering greater flexibility and accessibility from various locations and devices. In contrast, syngo.CT CaScoring (Tool B) is integrated with specific Siemens CT scanner systems and operates on the syngo.via platform, which may limit its deployment flexibility and access points.
Clinical Value
Cleerly LABSCleerly LABS (Tool A) provides a comprehensive analysis of CCTA, including detection, quantification, and characterization of atherosclerosis and stenosis, ischemia detection, and tracking disease progression over time. syngo.CT CaScoring (Tool B) focuses primarily on the quantification and visualization of calcified coronary lesions and Agatston scores, offering a more limited scope of clinical insight.
Pricing & Value
Cleerly LABSCleerly LABS (Tool A) offers transparent per-analysis pricing, allowing for clear cost estimation, and its comprehensive clinical insights provide significant value for personalized heart disease management. While syngo.CT CaScoring (Tool B) offers a one-time license, its pricing is opaque and its clinical scope is narrower, making it harder to assess its overall value without direct vendor contact and a clear understanding of usage volume.
Enterprise Readiness
Cleerly LABSCleerly LABS (Tool A) explicitly states HIPAA compliance and the availability of a Business Associate Agreement (BAA), along with integration capabilities with PACS, RIS, and EHR via a Cleerly Proxy. While syngo.CT CaScoring (Tool B) is from a major vendor (Siemens) and likely compliant, its BAA and HIPAA compliance are stated as 'likely' and require vendor contact for specifics, introducing a degree of uncertainty for enterprise deployment.
Innovation
Cleerly LABSCleerly LABS (Tool A) demonstrates greater innovation by moving beyond traditional calcium scoring to offer comprehensive plaque characterization (volume, type), stenosis detection, and the ability to track disease progression. syngo.CT CaScoring (Tool B), while AI-powered, primarily automates and enhances the established practice of coronary calcium scoring.
Support & Docs
TieBoth companies are established and likely offer robust support. Cleerly (Tool A) provides a dedicated support center. Siemens (Tool B), as a global healthcare technology provider, has an extensive support and documentation infrastructure for its syngo.via platform, of which CaScoring is a part. Without specific comparative metrics on response times, training, or depth of documentation, it is difficult to definitively choose a winner.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Cleerly LABS | syngo.CT CaScoring |
|---|---|---|
| Tool Name | Cleerly LABS | syngo.CT CaScoring |
| Company | Cleerly | Siemens Medical Solutions USA |
| Primary Purpose | AI-powered, FDA-cleared web-based software for comprehensive analysis of coronary CT angiography (CCTA) to detect, quantify, and characterize atherosclerosis and stenosis, aiding in personalized heart disease management. | AI-powered image analysis software for quick quantification and accurate visualization of calcified coronary lesions from CT scans, aiding in cardiovascular risk assessment and documentation. |
| Core Analysis Focus | Comprehensive coronary plaque assessment (volume, type), stenosis detection and quantification, ischemia detection (with Cleerly ISCHEMIA module). | Quantification and visualization of calcified coronary lesions. |
| Specific Scores/Quantifications | Comprehensive coronary plaque assessment (volume, type), stenosis detection and quantification, personalized heart disease risk assessment, tracking disease progression over time. | Agatston Score, volume, and calcium mass; assessment of plaque burden in total and per coronary artery (RCA, LM, LAD, CX); comparison to healthy reference groups (e.g., MESA study); 'Coronary Age'. |
Videos
Demos, reviews, and walkthroughs featuring Cleerly LABS and syngo.CT CaScoring.
Frequently Asked Questions
More Comparisons
More matchups featuring Cleerly LABS or syngo.CT CaScoring
Backers
Who funded each tool's parent company.